GTAB B — Glycorex Transplantation AB (publ) Share News
0.000.00%
- SEK125.77m
- SEK132.98m
- SEK38.84m
Brief: Glycorex Q2 Operating Income SEK -3.9 Million
Brief: Glycorex Q1 Net Loss at SEK 4.3 Million
Brief: Glycorex Posts Q4 Operating Loss of SEK 1.8 Million
Glycorex Q3 Operating Income SEK -800 Thousand
Brief: Glycorex Transplantation Q3 Operating Profit Turns To Loss Of SEK 0.4 Mln
Brief: Glycorex Transplantation: Geert Nygaard Appointed As New CEO
Brief: Glycorex Q2 Operating Loss Narrows To SEK 2.2 Mln
Brief: Glycorex Transplantation CEO Pontus Nobréus Leaves Co
Brief: Glycorex Transplantation: Significant Benefits Of Using Intraoperative Glycosorb Treatment For Blood Group Incompatible Pediatric Heart Transplants
Brief: Glycorex Transplantation Q1 Operating Loss At SEK 5.3 Mln
Brief: Glycorex Q4 Operating Result Swings To Loss SEK 2.5 Mln
Brief: Glycorex Transplantation: Glycosorb ABO Approved In Turkey
Brief: Glycorex Transplantation AB (Publ) Q3 Operating Profit Sek 1.1 Million
Brief: Glycorex Q2 Operating Result Swings To Loss Of SEK 6.4 Mln
Brief: Glycorex Transplantation Appoints Pontus Nobréus New CEO
Brief: Glycorex Q1 Operating Profit Falls To SEK 0.2 Million
Brief: Glycorex Transplantation CEO Johan Nilsson Leaves
Brief: Glycorex Transplantation Informs About Consequences Of Coronavirus
Brief: Glycorex Transplantation Q4 Operating Profit Down At SEK 0.9 Mln